{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T02:28:35Z","timestamp":1788056915504,"version":"build-2784847793"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jinf.2016.07.001","type":"journal-article","created":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T08:42:01Z","timestamp":1467967321000},"page":"314-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["De-escalation versus continuation of empirical antimicrobial therapy in community-acquired pneumonia"],"prefix":"10.1016","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2214-6695","authenticated-orcid":false,"given":"Hayato","family":"Yamana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Hirashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohide","family":"Fushimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Yasunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2016.07.001_bib1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/510393","article-title":"Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship","volume":"44","author":"Dellit","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2016.07.001_bib2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1378\/chest.118.1.146","article-title":"The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting","volume":"118","author":"Ibrahim","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.jinf.2016.07.001_bib3","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/01.CCM.0000050298.59549.4A","article-title":"Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome","volume":"31","author":"Leone","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jinf.2016.07.001_bib4","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1378\/chest.09-0087","article-title":"Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock","volume":"136","author":"Kumar","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.jinf.2016.07.001_bib5","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1097\/CCM.0b013e3181cc4824","article-title":"Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department","volume":"38","author":"Gaieski","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jinf.2016.07.001_bib6","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.280.14.1233","article-title":"Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella","volume":"280","author":"Rahal","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jinf.2016.07.001_bib7","doi-asserted-by":"crossref","first-page":"834","DOI":"10.7326\/0003-4819-136-11-200206040-00013","article-title":"The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, Enterococcus, gram-negative bacilli, Clostridium difficile, and Candida","volume":"136","author":"Safdar","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jinf.2016.07.001_bib8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.7326\/0003-4819-140-1-200401060-00008","article-title":"International prospective study of Klebsiella pneumonia bacteremia: implications of extended-spectrum \u03b2-lactamase production in nosocomial infections","volume":"140","author":"Paterson","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jinf.2016.07.001_bib9","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1086\/422647","article-title":"Predicting hospital rates of fluoroquinolone-resistance Pseudomonas aeruginosa from fluoroquinolone use in US hospitals and their surrounding communities","volume":"39","author":"Polk","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2016.07.001_bib10","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1097\/01.CCM.0000171849.04952.79","article-title":"Strategies to prevent antimicrobial resistance in the intensive care unit","volume":"33","author":"Kollef","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jinf.2016.07.001_bib11","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/01.CCM.0000202128.30405.60","article-title":"Providing appropriate antimicrobial therapy in the intensive care unit: surveillance vs. de-escalation","volume":"34","author":"Kollef","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jinf.2016.07.001_bib12","first-page":"CD007934","article-title":"De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock","volume":"3","author":"Silva","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jinf.2016.07.001_bib13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","article-title":"Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012","volume":"39","author":"Dellinger","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jinf.2016.07.001_bib14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","author":"American Thoracic Society","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl. 2","key":"10.1016\/j.jinf.2016.07.001_bib15","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2016.07.001_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00134-013-3077-7","article-title":"De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock","volume":"40","author":"Garnacho-Montero","year":"2014","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jinf.2016.07.001_bib17","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/1471-2334-14-272","article-title":"Bloodstream infections and sepsis in Greece: over-time change of epidemiology and impact of de-escalation on final outcome","volume":"14","author":"Koupetori","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2016.07.001_bib18","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1097\/01.CCM.0000145997.10438.28","article-title":"De-escalation therapy in ventilator-associated pneumonia","volume":"32","author":"Rello","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jinf.2016.07.001_bib19","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1378\/chest.129.5.1210","article-title":"Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia","volume":"129","author":"Kollef","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.jinf.2016.07.001_bib20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2147\/IDR.S65928","article-title":"Safety and feasibility of antibiotic de-escalation in bacteremic pneumonia","volume":"7","author":"Khasawneh","year":"2014","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jinf.2016.07.001_bib21","doi-asserted-by":"crossref","first-page":"R225","DOI":"10.1186\/cc9373","article-title":"De-escalation as part of a global strategy of empiric antibiotherapy management. A retrospective study in a medico-surgical intensive care unit","volume":"14","author":"Morel","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.jinf.2016.07.001_bib22","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s00134-014-3411-8","article-title":"De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial","volume":"40","author":"Leone","year":"2014","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jinf.2016.07.001_bib23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1465-9921-14-44","article-title":"Current management of patients hospitalized with community-acquired pneumonia across Europe: outcomes from REACH","volume":"14","author":"Blasi","year":"2013","journal-title":"Respir Res"},{"key":"10.1016\/j.jinf.2016.07.001_bib24","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMcp1214869","article-title":"Community-acquired pneumonia","volume":"370","author":"Wunderink","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2016.07.001_bib25","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0140-6736(11)60987-2","article-title":"Cost containment and quality of care in Japan: is there a trade-off?","volume":"378","author":"Hashimoto","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2016.07.001_bib26","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1183\/09031936.00081514","article-title":"Low-dose corticosteroid use and mortality in severe community-acquired pneumonia patients","volume":"45","author":"Tagami","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2016.07.001_bib27","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.jclinepi.2014.12.004","article-title":"Categorized diagnoses and procedure records in an administrative database improved mortality prediction","volume":"68","author":"Yamana","year":"2015","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jinf.2016.07.001_bib28","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.jinf.2016.07.001_bib29","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"Quan","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jinf.2016.07.001_bib30","first-page":"S79","article-title":"Guidelines for the management of community-acquired pneumonia in adults (revised edition)","volume":"11","author":"Committee for the Japanese Respiratory Society Guidelines for the Management of Respiratory Infections","year":"2006","journal-title":"Respirology"},{"key":"10.1016\/j.jinf.2016.07.001_bib31","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2169\/internalmedicine.45.1691","article-title":"The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations","volume":"45","author":"Miyashita","year":"2006","journal-title":"Intern Med"},{"key":"10.1016\/j.jinf.2016.07.001_bib32","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2169\/internalmedicine.50.4651","article-title":"Evaluation of an assessment system for the JRS 2005: A-DROP for the\u00a0management of CAP in adults","volume":"50","author":"Kohno","year":"2011","journal-title":"Intern Med"},{"key":"10.1016\/j.jinf.2016.07.001_bib33","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2176\/nmc.47.291","article-title":"Indications for computed tomography in patients with mild head injury","volume":"47","author":"Ono","year":"2007","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.1016\/j.jinf.2016.07.001_bib34","doi-asserted-by":"crossref","first-page":"e002736","DOI":"10.1136\/bmjopen-2013-002736","article-title":"The eye response test alone is sufficient to predict stoke outcome\u2014reintroduction of Japan Coma Scale: a cohort study","volume":"3","author":"Shigematsu","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.jinf.2016.07.001_bib35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12913-015-0889-x","article-title":"Procedure-based severity index for inpatients: development and validation using administrative database","volume":"15","author":"Yamana","year":"2015","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jinf.2016.07.001_bib36","doi-asserted-by":"crossref","first-page":"S249","DOI":"10.1086\/591411","article-title":"Position paper: recommended design features of future clinical trials of antibacterial agents for community-acquired pneumonia","volume":"47","author":"Infectious Diseases Society of America","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2016.07.001_bib37","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B","article-title":"Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group","volume":"17","author":"D'Agostino","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.jinf.2016.07.001_bib38","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1001\/jama.297.3.278","article-title":"Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods","volume":"297","author":"Stukel","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jinf.2016.07.001_bib39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","author":"WHO Expert Consultation","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2016.07.001_bib40","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research","volume":"38","author":"Austin","year":"2009","journal-title":"Commun Stat Simul Comput"},{"key":"10.1016\/j.jinf.2016.07.001_bib41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev.publhealth.19.1.17","article-title":"Econometrics in outcomes research: the use of instrumental variables","volume":"19","author":"Newhouse","year":"1998","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.jinf.2016.07.001_bib42","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/aje\/kwn299","article-title":"Instrumental variable analysis for estimation of treatment effects with dichotomous outcomes","volume":"169","author":"Rassen","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jinf.2016.07.001_bib43","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1136\/thx.2010.143982","article-title":"Microbial aetiology of community-acquired pneumonia and its relation to severity","volume":"66","author":"Cill\u00f3niz","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.jinf.2016.07.001_bib44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jinf.2013.03.003","article-title":"Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: results of a one-year study","volume":"67","author":"Musher","year":"2013","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2016.07.001_bib45","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1378\/chest.114.6.1588","article-title":"Etiology of community-acquired pneumonia in hospitalized patients: a 3-year prospective study in Japan","volume":"114","author":"Ishida","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.jinf.2016.07.001_bib46","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1099\/jmm.0.45920-0","article-title":"Community-acquired pneumonia in Japan: a prospective ambulatory and hospitalized patient study","volume":"54","author":"Miyashita","year":"2005","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jinf.2016.07.001_bib47","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/archinte.1988.00380090091022","article-title":"Antibiotic streamlining from combination therapy to monotherapy utilizing an interdisciplinary approach","volume":"148","author":"Briceland","year":"1988","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jinf.2016.07.001_bib48","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1378\/chest.128.4.2238","article-title":"Cost analyses of community-acquired pneumonia from the hospital perspective","volume":"128","author":"Bauer","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.jinf.2016.07.001_bib49","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/1471-2334-14-335","article-title":"Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis","volume":"14","author":"Spoorenberg","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2016.07.001_bib50","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/CCM.0b013e31824317bb","article-title":"De-escalation: in drug we trust","volume":"40","author":"Montravers","year":"2012","journal-title":"Crit Care Med"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445316301621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445316301621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:23:16Z","timestamp":1759008196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445316301621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0163445316301621"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2016.07.001","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"De-escalation versus continuation of empirical antimicrobial therapy in community-acquired pneumonia","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2016.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}